Comparative susceptibility of Gemella morbillorum to 13 antimicrobial agents.

Authors :: Goldstein EJ
Merriam CV
Claros MC
Citron DM
Source :: Anaerobe [Anaerobe] 2022 Jun; Vol. 75, pp. 102573. Date of Electronic Publication: 2022 Apr 18.
Publication Year :: 2022
Abstract: The in vitro activity of 13 antimicrobials against clinical isolates of Gemella morbillorum showed good susceptibility to clindamycin, all beta-lactams agents studied except cefoxitin (MIC <subscript>90,</subscript> 4 μg/ml) and fluoroquinolones. There was 36% metronidazole resistance.<br />Competing Interests: Declaration of competing interest No author has a conflict of interest.<br /> (Copyright © 2022 Elsevier Ltd. All rights reserved.)